Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MnA round-up: AAA bags Atreus; Pulmonx acquires Aeris

This article was originally published in Clinica

Executive Summary

Medtech M&A activity shows no sign of slowing down in the New Year, with two more deals. French nuclear imaging firm Advanced Accelerator Applications (AAA) has bought the remaining 49.9% stake in Canada’s Atreus Pharmaceuticals; while Pulmonx, a specialist in minimally-invasive treatments for pulmonary disorders, has acquired the assets of Aeris Therapeutics, including its AeriSeal foam-based lung sealant system for the treatment of emphysema.


Related Content

Pulmonx Reaches Multiple Milestones In Lung-Valve, Diagnostics Development





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts